Anaphylaxis Non-anaphylaxis p-value
N = 143 N= 92
Sex, males, n (%) 91 (63.6) 59 (64.1) 0.94
Age (year), median (Q1-Q3) 9 (6-13.5) 9.5 (7-14) 0.90
Previous/Initial clinical history, n (%) Previous/Initial clinical history, n (%) Previous/Initial clinical history, n (%) Previous/Initial clinical history, n (%)
Anaphylaxis 45 (31.5) 16 (17.4) 0.02
Urticaria 56 (39.2) 17 (18.5) 0.0008
Generalized oedema 47 (32.9) 31 (33.7) 0.90
Pruritus 11 (7.7) 9 (9.8) 0.58
Sneezing 0 (0) 1 (1.1) 0.39
Rhinitis 6 (4.2) 2 (2.2) 0.49
Oedema of larynx 5 (3.5) 2 (2.2) 0.71
Cough 19 (13.3) 5 (5.4) 0.05
Dyspnea 5 (3.5) 5 (5.4) 0.52
Dysphonia 4 (2.8) 0 (0) 0.16
Conjunctivitis 1 (0.7) 0 (0) 1
Abdominal pain 16 (11.2) 9 (9.8) 0.73
Vomiting 23 (16.1) 7 (7.6) 0.06
Nausea 3 (2.1) 2 (2.2) 1
Hypotension 4 (2.8) 2 (2.2) 1
Asthenia 0 (0) 2 (2.2) 0.15
Tachycardia 1 (0.7) 0 (0) 1
Clinical reaction during oral food challenge, n (%) Clinical reaction during oral food challenge, n (%) Clinical reaction during oral food challenge, n (%) Clinical reaction during oral food challenge, n (%)
Anaphylaxis 143 (100) 92 (100)
Urticaria 70 (49.0) 37 (40.2) 0.19
Generalized oedema 19 (13.3) 14 (15.2) 0.68
Localized Pruritus 43 (30.1) 39 (42.4) 0.05
Generalized Pruritus 3 (2.1) 1 (1.1) 1
Sneezing 2 (1.4) 0 (0) 0.52
Rhinitis 56 (39.2) 29 (31.5) 0.23
Oedema of larynx 3 (2.1) 0 (0) 0.28
Cough 47 (32.9) 3 (3.3) < 0.001
Dyspnea 10 (7.0) 0 (0) 0.01
Wheezing 11 (7.7) 2 (2.2) 0.07
Dysphonia 2 (1.4) 0 (0) 0.52
Conjunctivitis 8 (5.6) 10 (10.9) 0.14
Abdominal pain 87 (60.8) 28 (30.4) < 0.001
Vomiting 54 (37.8) 4 (4.3) < 0.001
Nausea 56 (39.2) 5 (5.4) < 0.001
Diarrhea 6 (4.2) 1 (1.1) 0.25
Hypotension 17 (11.9) 0 (0) 0.001
Asthenia 6 (4.2) 0 (0) 0.08
Tachycardia 5 (3.5) 0 (0) 0.16